Related Experiment Video
Updated: Aug 23, 2025
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
2'-Hydroxy-4',5'-dimethoxyacetophenone Exhibit Collagenase, Aldose Reductase Inhibition, and Anticancer Activity
1Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, Henan, China. chuyingna@sina.com.
Abstract:
Diabetes is a serious growing concern that affects many parts of the body including the skin due to high sugar levels. Moreover, diabetic patients are at risk of developing cancer and are prone to a higher risk of hematological malignancies. In the present study, the inhibitory effect of 2'-Hydroxy-4',5'-dimethoxyacetophenone was investigated on aldose reductase and collagenase enzymes, along with docking and ADMET analysis. MTT assay was also conducted to investigate the anti-leukemic effect of 2'-Hydroxy-4',5'-dimethoxyacetophenone on human acute leukemia cells (32D-FLT3-ITD, Human HL-60/vcr, MOLT-3, and TALL-104 cell lines) and DPPH assay for establishing activity against oxidative stress. The 2'-Hydroxy-4',5'-dimethoxyacetophenone showed potent inhibition of both the above tested enzymes with numerous strong interactions with the key catalytic residues in the active site of the enzymes. The MTT assay showed strong anti-cancer activity against entire tested human acute leukemia cells and was found non-toxic to normal (HUVEC) at the tested concentration. In DPPH free radical scavenging assay, 2'-Hydroxy-4',5'-dimethoxyacetophenone showed strong inhibitory activity with IC50 of 157 µg/mL, which found comparable to the standard BHT. Our study demonstrated prominent pharmacological benefit of 2'-Hydroxy-4',5'-dimethoxyacetophenone, against various leukemic cell lines, aldose reductase and collagenase enzymes, and free radical scavenging activity.
Insights
2'-Hydroxy-4',5'-dimethoxyacetophenone effectively inhibits aldose reductase, collagenase, and leukemia cell growth. This compound also demonstrates potent antioxidant activity, suggesting broad pharmacological benefits for diabetic and cancer patients.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Biochemistry
Background:
- Diabetes mellitus poses significant health risks, including increased susceptibility to cancers, particularly hematological malignancies.
- Diabetic complications often involve enzymatic dysregulation and oxidative stress, contributing to disease progression.
Purpose of the Study:
- To investigate the inhibitory potential of 2 -Hydroxy-4 ,5 -dimethoxyacetophenone against aldose reductase and collagenase enzymes.
- To evaluate the anti-leukemic effects of 2 -Hydroxy-4 ,5 -dimethoxyacetophenone on various human acute leukemia cell lines.
- To assess the antioxidant capacity of 2 -Hydroxy-4 ,5 -dimethoxyacetophenone using the DPPH assay.
Main Methods:
- Enzyme inhibition assays for aldose reductase and collagenase.
- Molecular docking studies to analyze enzyme-ligand interactions.
- MTT cytotoxicity assays on leukemia and normal cell lines.
- DPPH free radical scavenging assay.
Main Results:
- 2 -Hydroxy-4 ,5 -dimethoxyacetophenone exhibited potent inhibition against aldose reductase and collagenase, with significant interactions at catalytic sites.
- The compound demonstrated strong anti-leukemic activity across tested cell lines (32D-FLT3-ITD, HL-60/vcr, MOLT-3, TALL-104) and was non-toxic to normal HUVEC cells.
- DPPH assay revealed significant free radical scavenging activity (IC50 = 157 µg/mL), comparable to BHT.
Conclusions:
- 2 -Hydroxy-4 ,5 -dimethoxyacetophenone possesses significant pharmacological properties, including enzyme inhibition and anti-leukemic effects.
- The compound's antioxidant activity suggests potential therapeutic applications in managing oxidative stress associated with diabetes and cancer.
- These findings highlight 2 -Hydroxy-4 ,5 -dimethoxyacetophenone as a promising candidate for further drug development.
More Related Videos
08:19Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018